CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...

The trend of prescribing semaglutide to treat cardiovascular disease is expected to continue to grow. At the American College ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

For a variety of reasons, Globe Food contributor Kara Baskin took the leap and started Zepbound. But first she worried: "What ...

affordable supply of critical medicines Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist available as an injector pen and used along with diet and exercise to improve ...

Liraglutide injection represents Meitheal’s first commercial injector pen product and its first ... Liraglutide injection is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as ...

In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...

Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...

A glucagon pen is meant to be used in cases when hypoglycemia is not responsive to treatment or when a person has lost consciousness. Glucagon injection side effects tend to be mild and may include: ...